Company
Company
History
History
-
2024
-
2024.06 Selected as KDDF non-clinical project for Glioblastoma therapy
-
-
2023
-
2023.04 Selected as a commercialization project by the Korea Institute of Startup and Entrepreneurship Development: Selected as one of the top 100 startups for materials, parts, and equipment
-
-
2022
-
2022.12 Certified as a national new technology (NET) by the Ministry of Trade, Industry and Energy
Selected as a military service designated institution by the Military Manpower Administration -
2022.10 Factory registration
-
2022.05 ISO 9001 quality certification
-
2022.05 animal vaccine adjuvant development project with Z Company
-
2022.04 Stroke treatment research and development agreement with Hanyang University
-
2022.04 Selected as a project for rapid general-purpose vaccine technology development by Global Vaccine Leading Technology Center
-
2022.04 Selected as a future growth high value-added vaccine development project by Global Vaccine Leading Technology Center
-
-
2021
-
2021.11 Series B investment completed
Selected as a KRAS vaccine development project by Korea Drug Development fund -
2021.05 Patent registration of key materials
Investment promotion from Bionote -
2021.03 Agreement on research and development of cerebral infarction treatment with Inje University
-
2021.01 Agreement to develop treatment/prevention vaccine with Yonsei University Tuberculosis Research Institute
-
-
2020
-
2020.12 Selected as a BIG3 R&D project, BIG3 commercialization project by the Ministry of SMEs and Startups
-
2020.09 Signed a comprehensive partnership agreement with BioNote for development of COVID-19 vaccine, etc.
-
2020.08 Completed CMO consignment production of adjuvant
-
2020.07 Signed an agreement with Il-yang Pharm to develop a flu vaccine capable of intranasal administration/ store at room temperature/ cross-immune
-
-
2019
-
2019.10 Started clinical trial of Adjuvant for livestock with Company B
-
2019.07 Applied for 3 patents (core technologies related to vaccine adjuvants)
-
2019.05 Building a BL2 animal laboratory
-
2019.04 Series A investment completed
-
2019.01 Certification of Industrial R&D Center
Establishment of Vaccine and Adjuvant technology platform
-
-
2018
-
2018.07 Authorization of Venture Business
Selected as TIPS by the Ministry of SMEs and Startups -
2018.02 Establishment of NA Vaccine Institute
-